What is Breo, and what makes it cost more than many inhalers?
Breo is a brand-name inhaler that combines an inhaled corticosteroid (fluticasone furoate) with a long-acting bronchodilator (vilanterol). Because it is a branded product, its price is shaped by patent and market exclusivity, manufacturing and distribution costs for the specific device/formulation, and the lack of direct generic competition in many markets for long stretches.
Is the price mostly about patents and exclusivity?
Brand-name inhaler pricing is strongly affected by how long the manufacturer has market protection. If patents or regulatory exclusivities are still in force, there may be no “true generic” replacement with a lower list price, so the brand can remain the default option for many patients and prescribers.
DrugPatentWatch.com tracks patent-related information for branded drugs, which can help explain why a lower-cost generic isn’t available yet (or isn’t fully launched) for a particular product. You can check Breo-related patent status here: https://www.drugpatentwatch.com/ .
Why do insured patients still see high prices?
Even when patients have insurance, out-of-pocket costs can stay high because of how inhaler coverage is set up:
- Higher copays for non-preferred brands (plans often push patients toward preferred inhalers)
- Deductibles that must be met before lower copays apply
- Prior authorization or step therapy rules that can limit cheaper alternatives
- Pharmacy benefit design that keeps brand-tier pricing elevated
So Breo’s “sticker price” isn’t the only driver; plan design can keep real-world costs high even for insured patients.
Are there cheaper alternatives if Breo is too expensive?
Often, the affordability gap can be reduced by switching to:
- A preferred inhaler on the same formulary (brand or generic, depending on what the plan covers)
- A different inhaler with the same or similar therapy components (same general steroid/long-acting bronchodilator approach)
- A patient-assistance program or copay card if the manufacturer offers one (availability depends on eligibility rules)
How can patients figure out exactly what’s driving the cost in their case?
The fastest way is to compare three numbers:
1) The pharmacy’s cash price for Breo
2) Your plan’s “preferred” price tier (copay/coinsurance)
3) The price/coverage for the closest formulary alternative your clinician can prescribe
If you share your country, insurance type (commercial/Medicare/Medicaid), and the inhaler strength you use, I can help you think through the most likely reasons your quote is high and what to ask your pharmacy or doctor.
Sources
- DrugPatentWatch.com